Sarcoidosis drugs under scrutiny: do they trigger lymphoma?
NCT ID NCT07343401
First seen Jan 18, 2026 · Last updated Jun 23, 2026 · Updated 30 times
Summary
This completed study from Alexandria University followed 40 adults with lung sarcoidosis who were receiving or about to start immunosuppressive therapy. Over 12 months, researchers tracked whether any participants developed lymphoma, confirmed by lymph node biopsy. The goal was to understand if these treatments might increase cancer risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOIDOSIS LUNG are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Alexandria main university hospital
Alexandria, Asafra, 11511, Egypt
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If the results show a clear link, it could help doctors weigh the risks of immunosuppressive therapy in sarcoidosis patients.
What could go wrong
This is a small, observational study with only 40 participants, so findings may not apply to all patients. It cannot prove cause and effect.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.